Cadrenal Therapeutics, Inc. Stock: price and insider trades · United States

Cadrenal Therapeutics, Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). In the past year (18 October 2025 to 18 October 2026), 28 filings came from 3 insiders.

There is no open-market purchase to report; the filings show 27 sales worth €230k by 2 insiders. The totals exclude 13 filings filed without an amount. Szot Matthew K filed the largest sale, €59k, on 31 December 2025.

Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.

For context, the typical company on the same exchange (median of 5,808 companies) published 19 filings over the same period, against 28 filings here. Over the whole record (from 2023), the tally stands at 5 purchases and 37 sales.

Other companies in the same market with recent insider buying flagged by our signals: GameStop Corp. and Heico Corp. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.